ScholarIQanswers from OpenAlex & ORCID
Marco DiBonaventura
ResearcherPublications, citations & collaboration network
Marco DiBonaventura is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marco DiBonaventura have?
ScholarIQindexed works
Marco DiBonaventura has 332 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marco DiBonaventura have?
ScholarIQcitation count
Marco DiBonaventura has 10,208 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marco DiBonaventura?
ScholarIQh-index
Marco DiBonaventura has an h-index of 49 in OpenAlex.
What is the i10-index of Marco DiBonaventura?
ScholarIQi10-index
Marco DiBonaventura has an i10-index of 124 in OpenAlex.
What is the ORCID of Marco DiBonaventura?
ScholarIQorcid
The ORCID for Marco DiBonaventura is on the source record.
What is the OpenAlex record for Marco DiBonaventura?
ScholarIQopenalex
The OpenAlex for Marco DiBonaventura is on the source record.
What are the most-cited papers on Marco DiBonaventura?
ScholarIQmost cited works
Burden of Gastrointestinal Disease in the United States: 2012 Update
Anne F. Peery, Evan S. Dellon, Jennifer L. Lund, Seth D. Crockett, Christopher McGowan, William J. Bulsiewicz, Lisa M. Gangarosa, Michelle T. Thiny, Karyn Stizenberg, Douglas R. Morgan, Yehuda Ringel, Hannah P. Kim, Marco DiBonaventura, Charlotte Carroll, Jeffery K. Allen, Suzanne F. Cook, Robert S. Sandler, Michael D. Kappelman, Nicholas J. Shaheen
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Diamant Thaçi, C. Paul, Andrew Pink, Yoko Kataoka, Chia‐Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana A. Ionita, Rodney Sinclair, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, Hernán Valdez
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Melinda Gooderham, Gary Chan, Claire Feeney, Pinaki Biswas, Hernán Valdez, Marco DiBonaventura, Chudy I. Nduaka, Ricardo Rojo
A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
Marco DiBonaventura, Susan Gabriel, Leon Dupclay, Shaloo Gupta, Edward Kim
The Costs of Obesity in the Workplace
Eric Finkelstein, Marco DiBonaventura, Somali M. Burgess, B.C. Hale